Biotech · Private company · Mukilteo, WA, US
Kinea Bio, Inc.
Track this companyFree. Adds Kinea Bio, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards7
- Split-Intein Protein Ligation: Enabling AAV Delivery of Large Genes for Clinical Translation in Genetic Cardiac DiseasesFiscal year 2026 · $599.7KNIH RePORTER 1R44HL182563-01A1 · fetched Nov 12, 2026
- Scalable Non-viral Gene Delivery for Neuromuscular DiseasesFiscal year 2026 · $1MNIH RePORTER 4R44AR084978-02 · fetched Nov 12, 2026
- Development of novel genetic medicine approaches to treat orphan diseasesFiscal year 2026 · $796.2KNIH RePORTER 5R44AR083801-03 · fetched Nov 12, 2026
- Scalable Non-viral Gene Delivery for Neuromuscular DiseasesFiscal year 2025 · $306.9KNIH RePORTER 1R44AR084978-01A1 · fetched Nov 12, 2026
- Development of novel genetic medicine approaches to treat orphan diseasesFiscal year 2025 · $55KNIH RePORTER 3R44AR083801-02S1 · fetched Nov 12, 2026
- Development of novel genetic medicine approaches to treat orphan diseasesFiscal year 2025 · $1.2MNIH RePORTER 4R44AR083801-02 · fetched Nov 12, 2026
- Development of novel genetic medicine approaches to treat orphan diseasesFiscal year 2024 · $303.1KNIH RePORTER 1R44AR083801-01A1 · fetched Nov 12, 2026